JOURNAL OF BUON, cilt.20, sa.2, ss.479-486, 2015 (SCI-Expanded)
Introduction: In lymph node-negative, hormone-positive, and Her2-negative breast cancer patients, the benefits of adding adjuvant chemotherapy to hormonal therapy continue to be debated, especially for low to intermediate grade and small tumors.